Chong Kun Dang’s CKD-339 Enters Phase 3 in South Korea for Patients Uncontrolled on Monotherapy
CKD-339, an essential hypertension treatment under development by Chong Kun Dang, is advancing into a Phase 3 clinical trial in South Korea.
Search results for "hypertension treatment"
Beyond Facial Wrinkles: 5 Internal Factors Accelerating Biological Aging
Aging is an inevitable biological process, but the rate at which it occurs is largely within individual control.
Mild Cognitive Impairment Doesn’t Always Lead to Dementia—Early Diagnosis and Lifestyle Management Are Key
Sept. 21 marks Dementia Overcoming Day, a designated observance created to raise public awareness about preventing and...
When You Can’t Recall "Madeleine": Short Film Youngsikxty Spotlights Early Dementia Awareness
“Less ice in the oat latte… and, you know, that thing. What is it, the yellow round thing.
Can SVF Injections Delay Knee Replacement? Two-Year Tracking Shows 99% Avoided Surgery
As populations age, the treatment paradigm for degenerative knee osteoarthritis is shifting from early artificial joint...
Forget the 4.5-Hour Window: Why Stroke Care Means Acting Right Now
Stroke remains one of South Korea’s leading causes of death, carrying a high risk of lasting complications or...
Silent Killers in the Brain: Why Cerebral Aneurysms Go Unnoticed Until They Rupture
Most illnesses announce themselves through distinct warning signs, but cerebral aneurysms are different.
Hanmi Completes Key Phase 2 Dosing for Once-Weekly Rare Disease Drug Efpeglucagon
During normal digestion, dietary carbohydrates convert into glucose that circulates in the blood.
4 Things Older Adults Must Check Before Getting Dental Implants
Concerns over the safety of dental implants for older adults are rising following a series of fatal incidents at a...
Stopping Beta-Blockers After Heart Attack Safe for Stable Patients, Korea-France Study Finds
One medication many patients take long-term following a heart attack is a beta-blocker.